Garcia and his wife claim negligence on the part of Univeristy of Miami's Miller School of Medicine doctors exacerbated his ...
SPR announced the publication of long-term data in the journal Pain and Therapy from a cross-sectional follow-up survey of real-world patients (n=602) with chronic low back pain who had previously ...
A new way of treating these ulcers could brighten the future, however: light-emitting diodes (LEDs) tuned to the red end of ...
Roche (ROG: SIX) has discontinued two Huntington’s disease programs, ending the long-running development of tominersen after ...
If you live with a senior cat, noticing signs of vision loss in your friend can be heartbreaking, raising concerns about ...
Nir Naor appointed Chief Financial Officer effective July 23, 2026, bringing more than 20 years of finance and life sciences experience; Cory Anderson promoted to Executive Vice P ...
The CEO of Toronto’s University Health Network has a bold proposal: Canadian world domination in clinical enterprises ...
ATTR-CM treatment options narrowed after AstraZeneca and Ionis revealed their gene-silencing drug Wainua (eplontersen) failed ...
Newly released figures published on 1st July, 2026 by TheCable from the National Data Repository have drawn renewed attention to Nigeria’s HIV situation, revealing that approximately 1.70 million ...
Immutep and its investors are confident the company can salvage something from its cancelled lung cancer program.
Key Points Interested in Nyxoah SA? Here are five stocks we like better. Nyxoah said its U.S. Genio launch is gaining ...
Teva secures exclusive global rights to commercialize Polpharma Biologics’ biosimilar candidate to Ocrevus® (ocrelizumab), including both ...